Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40287 studies found for:    Open Studies | Senior
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Senior
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
Condition: Breast Cancer
Interventions: Drug: Carvedilol;   Other: placebo
2 Unknown  Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Conditions: Depression;   Adverse Reaction to Drug
Interventions: Drug: SSRI class antidepressant;   Drug: non-SSRI class antidepressant
3 Recruiting Incidence of Febrile Neutropenia
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
4 Not yet recruiting Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Vorinostat Velcade Dexamethasone
5 Recruiting Systematic Registration of All Big Toe Prostheses Placed in Ghent University Hospital
Condition: Big Toe Prosthesis
Intervention: Procedure: Registration of all big toe prostheses in Ghent University Hospital
6 Recruiting MRA Therapy Versus CPAP Therapy in Moderate OSAS
Condition: Sleep Apnea, Obstructive
Interventions: Device: mandibular repositioning appliance (MRA) (SomnoDent);   Procedure: Continuous positive airway pressure (CPAP)
7 Not yet recruiting Combination of Lenalidomide and Obinutuzumab (GA101) in Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Condition: Leukemia
Interventions: Drug: Lenalidomide;   Drug: Obinutuzumab
8 Recruiting Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant
Condition: Hematological Malignancies
Intervention: Biological: Naive T Cell Depleted Donor Lymphocyte Infusion
9 Recruiting Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: IgY;   Drug: Placebo
10 Recruiting Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection
Condition: Tuberculosis
Intervention:
11 Recruiting Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients
Condition: Liver Transplant Recipient
Interventions: Drug: micafungin;   Drug: Fluconazole
12 Unknown  Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
Conditions: Unstable Angina;   NSTEMI
Interventions: Drug: comparison of different dosage of clopidogrel;   Drug: doubled therapy
13 Recruiting Combi-Neo Study for Stage IV Melanoma
Conditions: Melanoma;   Malignant Melanoma Stage IV;   Metastatic Melanoma
Interventions: Drug: Dabrafenib;   Drug: Trametinib;   Procedure: Surgery
14 Unknown  Genetic Linkage Study for Hereditary Pancreatitis
Condition: Pancreatitis
Intervention: Procedure: genetic testing
15 Unknown  Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees
Condition: Substance-Related Disorders
Interventions: Behavioral: Collaborative Behavioral Management;   Procedure: Integrated parole and outpatient addiction treatment
16 Recruiting Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
Conditions: Multiple Myeloma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Romidepsin;   Drug: Lenalidomide
17 Unknown  Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma;   Kidney Neoplasm;   Renal Cancer;   Kidney Cancer
Intervention: Drug: Yttrium-90 conjugated chimeric G250 (90Y-cG250)
18 Recruiting Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy
Conditions: Periampullary Cancer;   Pancreatic Cancer
Interventions: Procedure: Endoscopic stenting;   Procedure: cholecystojejunostomy
19 Not yet recruiting Study 3: Minocycline Decreases Microglia Activation
Condition: Hypertension
Intervention: Other: Minocycline
20 Recruiting A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
Conditions: Breast Neoplasms;   BRCA 1 Gene Mutation;   BRCA 2 Gene Mutation
Interventions: Drug: talazoparib;   Drug: Physician's-Choice

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years